Literature DB >> 8094196

Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient.

E Schütz, J Gummert, F Mohr, M Oellerich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8094196     DOI： 10.1016/0140-6736(93)93028-y

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  40 in total

Review 1.  Pharmacogenomics: challenges and opportunities.

Authors:  Dan M Roden; Russ B Altman; Neal L Benowitz; David A Flockhart; Kathleen M Giacomini; Julie A Johnson; Ronald M Krauss; Howard L McLeod; Mark J Ratain; Mary V Relling; Huijun Z Ring; Alan R Shuldiner; Richard M Weinshilboum; Scott T Weiss
Journal:  Ann Intern Med       Date:  2006-11-21       Impact factor: 25.391

Review 2.  Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.

Authors:  Eveline Jaquenoud Sirot; Jan Willem van der Velden; Katharina Rentsch; Chin B Eap; Pierre Baumann
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

3.  Human thiopurine S-methyltransferase pharmacogenetics: variant allozyme misfolding and aggresome formation.

Authors:  Liewei Wang; Tien V Nguyen; Richard W McLaughlin; Laura A Sikkink; Marina Ramirez-Alvarado; Richard M Weinshilboum
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-20       Impact factor: 11.205

Review 4.  Pharmacogenetics of cancer therapy: getting personal.

Authors:  E Y Krynetski; W E Evans
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

5.  Association Between Thiopurine S-Methyltransferase (TPMT) Genetic Variants and Infection in Pediatric Heart Transplant Recipients Treated With Azathioprine: A Multi-Institutional Analysis.

Authors:  Dionna J Green; Son Q Duong; Gilbert J Burckart; Tristan Sissung; Douglas K Price; William D Figg; Maria M Brooks; Richard Chinnock; Charles Canter; Linda Addonizio; Daniel Bernstein; David C Naftel; Adriana Zeevi; James K Kirklin; Steven A Webber; Brian Feingold
Journal:  J Pediatr Pharmacol Ther       Date:  2018 Mar-Apr

6.  Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine.

Authors:  C L Szumlanski; R M Weinshilboum
Journal:  Br J Clin Pharmacol       Date:  1995-04       Impact factor: 4.335

7.  Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians.

Authors:  H L Tai; E Y Krynetski; C R Yates; T Loennechen; M Y Fessing; N F Krynetskaia; W E Evans
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

8.  Genetic polymorphisms of NQO1, CYP1A1 and TPMT and susceptibility to acute lymphoblastic leukemia in a Tunisian population.

Authors:  Slah Ouerhani; Nouha Cherif; Ikbel Bahri; Ines Safra; Samia Menif; Salem Abbes
Journal:  Mol Biol Rep       Date:  2012-10-14       Impact factor: 2.316

Review 9.  Cancer pharmacogenomics in children: research initiatives and progress to date.

Authors:  Shahrad Rod Rassekh; Colin J D Ross; Bruce C Carleton; Michael R Hayden
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

10.  Thiopurine S-methyltransferase pharmacogenetics: autophagy as a mechanism for variant allozyme degradation.

Authors:  Fang Li; Liewei Wang; Rebecca J Burgess; Richard M Weinshilboum
Journal:  Pharmacogenet Genomics       Date:  2008-12       Impact factor: 2.089
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.